To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after TKA

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
January 2015

Ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after TKA

Vol: 4| Issue: 1| Number:9| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Randomized trial comparing ferric carboxymaltose vs oral ferrous glycine sulphate for postoperative anaemia after total knee arthroplasty

Br J Anaesth. 2014 Sep;113(3):402-9.

Contributing Authors:
E Bisbe L Moltó R Arroyo JM Muniesa M Tejero

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

122 adult patients with anaemia, iron deficiency, or both following total knee arthroplasty were randomly allocated to receive intravenous ferric carboxymaltose (FCM) or oral ferrous glycine sulphate (FS), with the purpose of comparing changes in hemoglobin (Hb) levels from postoperative day 4 to 30. Patients who received intravenous FCM experienced significantly greater changes in hemoglobin leve...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue